Document is current
Any future updates will be listed below
-
Authors
Levi, Jelena https://orcid.org/0000-0002-0846-0795
Guglielmetti, Caroline
Henrich, Timothy J. https://orcid.org/0000-0002-6684-0622
Yoon, John C. https://orcid.org/0000-0003-1123-5668
Gokhale, Prafulla C. https://orcid.org/0000-0002-1974-5921
Reardon, David A. https://orcid.org/0000-0001-6674-0157
Packiasamy, Juliet
Huynh, Lyna
Cabrera, Hilda
Ruzevich, Marisa
Blecha, Joseph
Peluso, Michael J. https://orcid.org/0000-0003-0585-6230
Huynh, Tony L. https://orcid.org/0000-0003-2964-1795
An, Sung-Min
Dornan, Mark
Belanger, Anthony P. https://orcid.org/0000-0001-9082-9514
Nguyen, Quang-Dé
Seo, Youngho https://orcid.org/0000-0001-5908-6636
Song, Hong
Chaumeil, Myriam M. https://orcid.org/0000-0002-2110-4613
VanBrocklin, Henry F.
Chae, Hee-Don
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (75N91019C00012)
- License Information
-
More Information
Article History
Received: 15 January 2024
Accepted: 22 June 2024
First Online: 1 July 2024
Competing interests
: The authors declare the following competing interests: J.L., J.P., L.H., H.C., M.R., and H.C. are or were employed by CellSight Technologies. J.L. holds patents related to [<sup>18</sup>F]F-AraG. All other authors declare no competing interests.
